Description

Opdivo is a medication used in cancer immunotherapy, specifically as a programmed death receptor-1 (PD-1) inhibitor. It works by enhancing the body's immune response against cancer cells, making it effective for various types of cancers, including melanoma and lung cancer.

Interpreter Notes

Interpreters should be aware that Opdivo may be referred to by its generic name, nivolumab, in some contexts. It is essential to maintain a formal register and avoid colloquial terms. Stick to the term 'Opdivo' in clinical discussions to ensure clarity.

Example Sentences

EN: The oncologist recommended Opdivo as part of the treatment plan for the patient's advanced melanoma.

ES: El oncólogo recomendó Opdivo como parte del plan de tratamiento para el melanoma avanzado del paciente.

Common Interpreter Mistakes

Confusing Opdivo with other cancer medications; mispronouncing 'Opdivo' as if it were a Spanish word; using informal terms instead of the clinical name.